Clearbridge Health's second batch of the Sinopharm Covid-19 vaccine has arrived in Singapore, according to a filing to the Singapore Exchange (SGX) on Sept 22.

The group’s first shipment of the Sinopharm vaccine arrived on August 28 and was fully allocated by early September.

Clearbridge Health acquired the vaccines from manufacturers in China, including China National Biotec Group Company Limited (CNBG) and Beijing Institute of Biological Product Co, a subsidiary of CNBG.


To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook